ES2536638T3 - Alteración dirigida de ADN - Google Patents
Alteración dirigida de ADN Download PDFInfo
- Publication number
- ES2536638T3 ES2536638T3 ES11791641.1T ES11791641T ES2536638T3 ES 2536638 T3 ES2536638 T3 ES 2536638T3 ES 11791641 T ES11791641 T ES 11791641T ES 2536638 T3 ES2536638 T3 ES 2536638T3
- Authority
- ES
- Spain
- Prior art keywords
- dna sequence
- oligonucleotide
- mismatch
- double
- directed dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Procedimiento para la alteración dirigida de una secuencia de ADN aceptor de doble cadena que comprende una primera secuencia de ADN y una segunda secuencia de ADN que es el complemento de la primera secuencia de ADN, comprendiendo el procedimiento combinar la secuencia de ADN aceptor de doble cadena con un oligonucleótido donante, en el que el oligonucleótido comprende al menos un dominio que es capaz de hibridarse a la primera secuencia de ADN, cuyo dominio comprende o está directamente adyacente a al menos un desapareamiento con respecto a la primera secuencia de ADN, y en el que dicho al menos un desapareamiento se encuentra como máximo 2 nucleótidos, preferiblemente como máximo 1 nucleótido del extremo 3' de dicho oligonucleótido, lo más preferiblemente dicho al menos un desapareamiento está en el extremo 3' del oligonucleótido, en el que el procedimiento no es para el tratamiento de un cuerpo humano o animal mediante terapia o para modificar la identidad genética de la línea germinal de seres humanos.
Description
Claims (1)
-
imagen1 imagen2
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41917910P | 2010-12-02 | 2010-12-02 | |
US419179P | 2010-12-02 | ||
NL2005808 | 2010-12-03 | ||
NL2005808 | 2010-12-03 | ||
PCT/NL2011/050804 WO2012074385A1 (en) | 2010-12-02 | 2011-11-25 | Targeted alteration of dna |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2536638T3 true ES2536638T3 (es) | 2015-05-27 |
Family
ID=44193925
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES14195788.6T Active ES2588482T3 (es) | 2010-12-02 | 2011-11-25 | Alteración dirigida de ADN |
ES11791641.1T Active ES2536638T3 (es) | 2010-12-02 | 2011-11-25 | Alteración dirigida de ADN |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES14195788.6T Active ES2588482T3 (es) | 2010-12-02 | 2011-11-25 | Alteración dirigida de ADN |
Country Status (11)
Country | Link |
---|---|
US (1) | US9150854B2 (es) |
EP (2) | EP2857512B1 (es) |
JP (1) | JP6084929B2 (es) |
CN (1) | CN103459596B (es) |
AU (1) | AU2011337323B2 (es) |
CA (1) | CA2819423C (es) |
DK (2) | DK2646549T3 (es) |
ES (2) | ES2588482T3 (es) |
HU (1) | HUE030490T2 (es) |
IL (1) | IL226536A (es) |
WO (1) | WO2012074385A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2536640T3 (es) | 2010-12-02 | 2015-05-27 | Keygene N.V. | Alteración dirigida de ADN con oligonucleótidos |
US20150064149A1 (en) * | 2013-09-04 | 2015-03-05 | Mice With Horns, LLC. | Materials and methods for correcting recessive mutations in animals |
WO2016105185A1 (en) | 2014-12-22 | 2016-06-30 | Keygene N.V. | Plant callus populations |
WO2018115389A1 (en) | 2016-12-22 | 2018-06-28 | Keygene N.V. | Methods of targeted genetic alteration in plant cells |
IL273460B1 (en) * | 2017-09-19 | 2024-03-01 | Tropic Biosciences Uk Ltd | Changing the specificity of plant non-coding RNA sequences to silence gene expression |
US20210238612A1 (en) | 2018-07-12 | 2021-08-05 | Keygene N.V. | Type v crispr/nuclease-system for genome editing in plant cells |
EP3874048A1 (en) | 2018-11-01 | 2021-09-08 | Keygene N.V. | Dual guide rna for crispr/cas genome editing in plants cells |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US579597A (en) | 1897-03-30 | Apparatus for heating blooms or other articles of metal | ||
US5556747A (en) * | 1990-07-09 | 1996-09-17 | E. R. Squibb & Sons, Inc. | Method for site-directed mutagenesis |
US6136601A (en) | 1991-08-21 | 2000-10-24 | Epoch Pharmaceuticals, Inc. | Targeted mutagenesis in living cells using modified oligonucleotides |
US5594121A (en) | 1991-11-07 | 1997-01-14 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
US5731181A (en) | 1996-06-17 | 1998-03-24 | Thomas Jefferson University | Chimeric mutational vectors having non-natural nucleotides |
AU4966997A (en) | 1996-11-18 | 1998-06-10 | Takeshi Imanishi | Novel nucleotide analogues |
JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
EP1557424A1 (en) | 1997-09-12 | 2005-07-27 | Exiqon A/S | Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues |
US6010907A (en) | 1998-05-12 | 2000-01-04 | Kimeragen, Inc. | Eukaryotic use of non-chimeric mutational vectors |
KR20020013513A (ko) | 1999-03-18 | 2002-02-20 | 추후제출 | Xylo-lna 유사체 |
NZ514348A (en) | 1999-05-04 | 2004-05-28 | Exiqon As | L-ribo-LNA analogues |
US6936467B2 (en) | 2000-03-27 | 2005-08-30 | University Of Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
NZ521698A (en) | 2000-03-27 | 2004-08-27 | Univ Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
AU2001263271A1 (en) | 2000-05-17 | 2001-11-26 | University Of Delaware | Plant gene targeting using oligonucleotides |
US20020119570A1 (en) | 2000-09-25 | 2002-08-29 | Kyonggeun Yoon | Targeted gene correction by single-stranded oligodeoxynucleotides |
AU2002322435A1 (en) | 2001-08-09 | 2003-02-24 | Cibus Genetics | Non-transgenic herbicide resistant plants |
EP1446503A2 (en) | 2001-09-27 | 2004-08-18 | University Of Delaware | Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration |
WO2006064813A1 (ja) * | 2004-12-13 | 2006-06-22 | National University Corporation Hokkaido University | 核酸構築物及びそれを利用した標的領域への変異導入方法 |
WO2007073149A1 (en) | 2005-12-22 | 2007-06-28 | Keygene N.V. | Alternative nucleotides for improved targeted nucleotide exchange |
KR20100051795A (ko) * | 2007-06-22 | 2010-05-18 | 키진 엔.브이. | 향상된 변형 올리고뉴클레오티드를 이용한 표적화 뉴클레오티드 교환 |
ATE555219T1 (de) * | 2008-08-12 | 2012-05-15 | Hoffmann La Roche | Korrekturlese-primerverlängerung |
ES2536640T3 (es) | 2010-12-02 | 2015-05-27 | Keygene N.V. | Alteración dirigida de ADN con oligonucleótidos |
-
2011
- 2011-11-25 CN CN201180066385.6A patent/CN103459596B/zh not_active Expired - Fee Related
- 2011-11-25 EP EP14195788.6A patent/EP2857512B1/en active Active
- 2011-11-25 HU HUE14195788A patent/HUE030490T2/en unknown
- 2011-11-25 US US13/991,060 patent/US9150854B2/en active Active
- 2011-11-25 AU AU2011337323A patent/AU2011337323B2/en not_active Ceased
- 2011-11-25 ES ES14195788.6T patent/ES2588482T3/es active Active
- 2011-11-25 CA CA2819423A patent/CA2819423C/en active Active
- 2011-11-25 DK DK11791641.1T patent/DK2646549T3/en active
- 2011-11-25 WO PCT/NL2011/050804 patent/WO2012074385A1/en active Application Filing
- 2011-11-25 EP EP11791641.1A patent/EP2646549B1/en active Active
- 2011-11-25 JP JP2013541944A patent/JP6084929B2/ja active Active
- 2011-11-25 DK DK14195788.6T patent/DK2857512T3/en active
- 2011-11-25 ES ES11791641.1T patent/ES2536638T3/es active Active
-
2013
- 2013-05-23 IL IL226536A patent/IL226536A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2646549A1 (en) | 2013-10-09 |
CN103459596B (zh) | 2016-12-14 |
WO2012074385A1 (en) | 2012-06-07 |
EP2857512B1 (en) | 2016-06-29 |
DK2646549T3 (en) | 2015-05-26 |
HUE030490T2 (en) | 2017-05-29 |
CA2819423A1 (en) | 2012-06-07 |
JP6084929B2 (ja) | 2017-02-22 |
AU2011337323A2 (en) | 2013-07-11 |
CA2819423C (en) | 2020-12-22 |
CN103459596A (zh) | 2013-12-18 |
AU2011337323A1 (en) | 2013-06-20 |
US9150854B2 (en) | 2015-10-06 |
JP2014500727A (ja) | 2014-01-16 |
AU2011337323B2 (en) | 2015-11-26 |
DK2857512T3 (en) | 2016-10-03 |
EP2857512A1 (en) | 2015-04-08 |
ES2588482T3 (es) | 2016-11-03 |
US20140004607A1 (en) | 2014-01-02 |
IL226536A (en) | 2016-03-31 |
EP2646549B1 (en) | 2015-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2536638T3 (es) | Alteración dirigida de ADN | |
MX2023008478A (es) | Nucleótidos modificados con 5´-ciclo-fosfonato. | |
CL2018000119A1 (es) | Compuestos pirazolo[1,5-a]piridina sustituidos como inhibidores de quinasa de ret. | |
ES2536640T3 (es) | Alteración dirigida de ADN con oligonucleótidos | |
CO2020010342A2 (es) | Composiciones de arni de 17 β -hidroxiesteroide deshidrogenasas tipo 13 (hsd17b13) y métodos de uso de las mismas | |
ECSP10010618A (es) | Análogos carba - nucleósidos para tratamiento antiviral | |
UY40039A (es) | COMPOSICIONES DE ARNi DEL COMPONENTE DEL COMPLEMENTO C5 Y MÉTODOS PARA SU USO | |
CL2014000210A1 (es) | Una composicion de prodroga que comprende al menos un conjugado de metilfenidato; kit farmaceutico que la comprende, util para el tratamiento de una enfermedad o condicion que requiere estimulacion del sistema nervioso tal como un trastorno de hiperactividad con deficit de atencion y depresion. | |
AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
GT201500330A (es) | Composiciones y métodos de uso de interferencia de arn en serpina 1 | |
MX2009011025A (es) | Compuestos con actividad anticancer. | |
CR20110441A (es) | Preparaciones para la sincronicación de ciclo estral y protocolos sin cidr efectivos. | |
AR081209A1 (es) | Tratamiento de enfermedades relacionadas con la proteina 11 del tipo linfoma 2 de celulas b, (bcl2, bcl2l11) mediante la inhibicion del transcripto antisentido natural a bcl2l11 | |
HN2011002480A (es) | Combinaciones de principios activos nematicidas, insecticidas y acaricidas que comprenden piridiletilbenzamidad e insecticidas. | |
UA109650C2 (xx) | Біс-арилзв'язані арилтриазолони та їх застосування | |
EA201400990A1 (ru) | Ингибиторы диацилглицеринацилтрансферазы 2 | |
UY30042A1 (es) | Nuevos derivados de alquilfosfolípidos con citotoxicidad reducida y usos de los mismos. | |
BR112017002629A2 (pt) | decoys de oligonucleotídeo para o tratamento de dor | |
AR113725A1 (es) | Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda (ahpnd) o el síndrome de la mancha blanca (wss), que comprende una cepa de bacillus subtilis, una cepa de bacillus pumilus y una cepa de bacillus licheniformis como principios activos | |
EA201791471A1 (ru) | Способы применения антисмысловых олигонуклеотидов smad7 | |
ES2673406T3 (es) | Alfa-derivados de ácidos grasos cis-monoinsaturados para uso como medicamentos en el tratamiento de la diabetes | |
ES2621824T3 (es) | Uso de MicroRNA-199B-5P en el campo médico y de diagnóstico | |
AR083445A1 (es) | siARN CONTRA LA FIBROSIS | |
CO6311056A2 (es) | Composicion y procedimiento para el tratamiento de la cercosporiosis del banano | |
AR095559A1 (es) | Monoterapia con oligonucleótidos anti-clusterina para tratar el cáncer |